Sulphated polymers are potent and selective inhibitors of various enveloped viruses, including herpes simplex virus, cytomegalovirus, vesicular stomatitis virus, respiratory syncytial virus, and toga-, arena- and retroviruses

被引:93
作者
Schols, D. [1 ]
De Ctercq, E. [1 ]
Balzanni, J. [1 ]
Baba, M. [1 ,5 ]
Witvrouw, M. [1 ]
Hosoya, M. [1 ]
Andrei, G. [1 ]
Snoeck, R. [1 ]
Neyts, J. [1 ]
Pauwels, R. [1 ]
Nagy, M. [2 ]
Gyorgyi-Edelenyi, J. [2 ]
Machovich, R. [3 ]
Horvath, I [3 ]
Low, M. [4 ]
Gorog, S. [4 ]
机构
[1] Katholieke Univ Leuven, Rega Inst Med Res, B-3000 Leuven, Belgium
[2] Eotvos Lorand Univ, Dept Colloid Sci, Budapest, Hungary
[3] Semmelweis Univ, Med Sch, Inst Biochem 2, Budapest, Hungary
[4] Chem Works Gedeon Richter Ltd, Budapest, Hungary
[5] Fukushima Med Coll, Dept Bacteriol, Fukushima, Japan
关键词
D O I
10.1177/095632029000100402
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The sulphated polymers, such as polyvinylalcohol sulphate (PVAS) and its co-polymer with acrylic acid (PAVAS), have proved to be potent inhibitors for herpes simplex virus, human cytomegalovirus, vesicular stomatitis virus, respiratory syncytial virus, Sindbis virus, Semliki Forest virus, Junin virus, Tacaribe virus, murine sarcoma virus and human immunodeficiency virus. They are not inhibitory to non-enveloped viruses, such as poliovirus and reovirus. The broad-spectrum antiviral effects of these compounds depend on their molecular weight and degree of sulphation. Pharmacokinetic studies in rabbits have indicated that after intravenous bolus injection the serum concentrations of these compounds decay biphasically, with an initial half-life of approximately 90-120 min.
引用
收藏
页码:233 / 240
页数:8
相关论文
共 34 条
[1]   PENTOSAN POLYSULFATE, A SULFATED OLIGOSACCHARIDE, IS A POTENT AND SELECTIVE ANTI-HIV AGENT INVITRO [J].
BABA, M ;
NAKAJIMA, M ;
SCHOLS, D ;
PAUWELS, R ;
BALZARINI, J ;
DECLERCQ, E .
ANTIVIRAL RESEARCH, 1988, 9 (06) :335-343
[2]   NOVEL SULFATED POLYMERS AS HIGHLY POTENT AND SELECTIVE INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS-REPLICATION AND GIANT-CELL FORMATION [J].
BABA, M ;
SCHOLS, D ;
DECLERCO, E ;
PAUWELS, R ;
NAGY, M ;
GYORGYIEDELENYI, J ;
LOW, M ;
GOROG, S .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (01) :134-138
[3]   MECHANISM OF INHIBITORY EFFECT OF DEXTRAN SULFATE AND HEPARIN ON REPLICATION OF HUMAN IMMUNODEFICIENCY VIRUS INVITRO [J].
BABA, M ;
PAUWELS, R ;
BALZARINI, J ;
ARNOUT, J ;
DESMYTER, J ;
DECLERCQ, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (16) :6132-6136
[4]   SULFATED POLYSACCHARIDES ARE POTENT AND SELECTIVE INHIBITORS OF VARIOUS ENVELOPED VIRUSES, INCLUDING HERPES-SIMPLEX VIRUS, CYTOMEGALO-VIRUS, VESICULAR STOMATITIS-VIRUS, AND HUMAN IMMUNODEFICIENCY VIRUS [J].
BABA, M ;
SNOECK, R ;
PAUWELS, R ;
DECLERCQ, E .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (11) :1742-1745
[5]   MARKED INVIVO ANTIRETROVIRUS ACTIVITY OF 9-(2-PHOSPHONYLMETHOXY-ETHYL)ADENINE, A SELECTIVE ANTI-HUMAN IMMUNODEFICIENCY VIRUS AGENT [J].
BALZARINI, J ;
NAESENS, L ;
HERDEWIJN, P ;
ROSENBERG, I ;
HOLY, A ;
PAUWELS, R ;
BABA, M ;
JOHNS, DG ;
DECLERCQ, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (01) :332-336
[6]   ISOLATION OF A T-LYMPHOTROPIC RETROVIRUS FROM A PATIENT AT RISK FOR ACQUIRED IMMUNE-DEFICIENCY SYNDROME (AIDS) [J].
BARRESINOUSSI, F ;
CHERMANN, JC ;
REY, F ;
NUGEYRE, MT ;
CHAMARET, S ;
GRUEST, J ;
DAUGUET, C ;
AXLERBLIN, C ;
VEZINETBRUN, F ;
ROUZIOUX, C ;
ROZENBAUM, W ;
MONTAGNIER, L .
SCIENCE, 1983, 220 (4599) :868-871
[7]   THE CD4 (T4) ANTIGEN IS AN ESSENTIAL COMPONENT OF THE RECEPTOR FOR THE AIDS RETROVIRUS [J].
DALGLEISH, AG ;
BEVERLEY, PCL ;
CLAPHAM, PR ;
CRAWFORD, DH ;
GREAVES, MF ;
WEISS, RA .
NATURE, 1984, 312 (5996) :763-767
[8]   COMPARATIVE EFFICACY OF ANTIHERPES DRUGS AGAINST DIFFERENT STRAINS OF HERPES-SIMPLEX VIRUS [J].
DECLERCQ, E ;
DESCAMPS, J ;
VERHELST, G ;
WALKER, RT ;
JONES, AS ;
TORRENCE, PF ;
SHUGAR, D .
JOURNAL OF INFECTIOUS DISEASES, 1980, 141 (05) :563-574
[9]  
DECLERCQ E, 1971, P SOC EXP BIOL MED, V137, P590
[10]  
HASELTINE WA, 1988, J ACQ IMMUN DEF SYND, V1, P217